Prevalence and characterization of treatment‐refractory psoriasis and super‐responders to biologic treatment: a nationwide study

202248 citationsJournal Articlebronze Open Access

Authors

Nikolai Loft · University of Copenhagen

Alexander Egeberg · University of Copenhagen

Mads Kirchheiner Rasmussen · Aarhus University Hospital

Lars Erik Bryld · Zealand University Hospital

C. Nissen · Bispebjerg Hospital

T.N. Dam · Sjællands Universitetshospital, Nykøbing F.

Kawa Khaled Ajgeiy

Abstract

A small proportion of patients with psoriasis treated with biologics are either super-responders or treatment refractory. Treatment refractory patients have higher body weight, whereas super-responders have fewer comorbidities and higher socioeconomic status.

Topics & Keywords

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Health Systems, Economic Evaluations, Quality of Life

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the European Academy of Dermatology and Venereology

Volume 36, Issue 8, pp. 1284-1291

DOI: 10.1111/jdv.18126

Field-Weighted Citation Impact: 3.57